Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Cognitive Impairment in Schizophrenia
NCT05838573Phase 3Completed
- Sponsor
- Central South University
- Start
- May 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in schizophrenia, sponsored by Central South University. Started May 2023; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT05838573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05838573.